National Vision Holdings Inc. Stock News

Although the revenue and EPS for National Vision (EYE) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wa

DULUTH, Ga.--(BUSINESS WIRE)--National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today reported its financial results for the fourth quarter and fiscal year ende

Evaluate the expected performance of National Vision (EYE) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key

National Vision's (EYE) impending termination of the long-term partnership with Walmart is likely to significantly impact its business.

DULUTH, Ga.--(BUSINESS WIRE)--National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) will report its fourth quarter and fiscal 2023 financial results before the mark

DULUTH, Ga.--(BUSINESS WIRE)--National Vision Holdings, Inc. (NASDAQ: EYE), the nation's second largest optical retailer providing quality, affordable eye care and eyewear, announced today the appoint

Investors are optimistic about National Vision's (EYE) stock, banking on strong solvency and promising future strategies.

In terms of store expansion, National Vision (EYE) continues to see sizable new opportunities for many years to come.

National Vision Holdings has experienced a decline in stock price due to the termination of its partnership with Walmart. Despite mixed financial performance, the company has a plan to recoup losses a

Investors are optimistic about National Vision's (EYE) stock, banking on comparable store sales growth and a favorable liquidity structure.

National Vision (EYE) is expanding sales by the continued rollout of its remote medicine technology.

National Vision's (EYE) higher SG&A expenses in the third quarter reflect increases in performance-based incentives and stock-based compensations.

National Vision Holdings, Inc. (NASDAQ:EYE ) Q3 2023 Earnings Conference Call November 9, 2023 8:30 AM ET Company Participants Caitlin Churchill - IR Reade Fahs - CEO Melissa Rasmussen - CFO Patrick M

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest

Investors with an interest in Medical - Products stocks have likely encountered both National Vision (EYE) and Insulet (PODD). But which of these two stocks is more attractive to value investors?